Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-31The intangible assets have finite, useful lives, and will be amortised on a straight line basis over the following useful life: The amortisation period and the amortisation method are reviewed at least at each financial year end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortisation period or method, as appropriate, and are treated as changes in accounting estimates. Gains or losses arising from derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the carrying amount of the asset and are recognised in the income statement when the asset is derecognised. Costs associated with maintaining computer software are recognised as an expense as incurred. Intangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Intangible assets with finite lives are amortised over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.truetrue2025-01-01truetrue102truetruetruetruetruetruefalsefalse96 03514931 2025-01-01 2025-12-31 03514931 2024-01-01 2024-12-31 03514931 2025-12-31 03514931 2024-12-31 03514931 2024-01-01 03514931 1 2025-01-01 2025-12-31 03514931 d:Director1 2025-01-01 2025-12-31 03514931 d:Director2 2025-01-01 2025-12-31 03514931 d:Director2 2025-12-31 03514931 d:RegisteredOffice 2025-01-01 2025-12-31 03514931 c:Buildings c:ShortLeaseholdAssets 2025-01-01 2025-12-31 03514931 c:Buildings c:ShortLeaseholdAssets 2025-12-31 03514931 c:Buildings c:ShortLeaseholdAssets 2024-12-31 03514931 c:OfficeEquipment 2025-01-01 2025-12-31 03514931 c:OfficeEquipment 2025-12-31 03514931 c:OfficeEquipment 2024-12-31 03514931 c:OfficeEquipment c:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 03514931 c:OwnedOrFreeholdAssets 2025-01-01 2025-12-31 03514931 c:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 03514931 c:CurrentFinancialInstruments 2025-12-31 03514931 c:CurrentFinancialInstruments 2024-12-31 03514931 c:CurrentFinancialInstruments c:WithinOneYear 2025-12-31 03514931 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 03514931 c:Non-currentFinancialInstruments c:AfterOneYear 2025-12-31 03514931 c:Non-currentFinancialInstruments c:AfterOneYear 2024-12-31 03514931 e:UnitedKingdom 2025-01-01 2025-12-31 03514931 e:UnitedKingdom 2024-01-01 2024-12-31 03514931 c:UKTax 2025-01-01 2025-12-31 03514931 c:UKTax 2024-01-01 2024-12-31 03514931 c:ShareCapital 2025-01-01 2025-12-31 03514931 c:ShareCapital 2025-12-31 03514931 c:ShareCapital 2024-01-01 2024-12-31 03514931 c:ShareCapital 2024-12-31 03514931 c:ShareCapital 2024-01-01 03514931 c:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 03514931 c:RetainedEarningsAccumulatedLosses 2025-12-31 03514931 c:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 03514931 c:RetainedEarningsAccumulatedLosses 2024-12-31 03514931 c:RetainedEarningsAccumulatedLosses 2024-01-01 03514931 c:AcceleratedTaxDepreciationDeferredTax 2025-12-31 03514931 c:AcceleratedTaxDepreciationDeferredTax 2024-12-31 03514931 c:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2025-12-31 03514931 c:FurtherSpecificTypeProvisionContingentLiability1ComponentTotalProvisionsContingentLiabilities 2024-12-31 03514931 d:OrdinaryShareClass1 2025-01-01 2025-12-31 03514931 d:OrdinaryShareClass1 2025-12-31 03514931 d:OrdinaryShareClass1 2024-12-31 03514931 d:FRS101 2025-01-01 2025-12-31 03514931 d:Audited 2025-01-01 2025-12-31 03514931 d:FullAccounts 2025-01-01 2025-12-31 03514931 d:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 03514931 2 2025-01-01 2025-12-31 03514931 c:CurrentFinancialInstruments 7 2025-12-31 03514931 c:CurrentFinancialInstruments 7 2024-12-31 03514931 c:Non-currentFinancialInstruments 6 2025-12-31 03514931 c:Non-currentFinancialInstruments 6 2024-12-31 03514931 g:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 03514931









STARLAB (UK), LTD.









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

 
STARLAB (UK), LTD.
 
 
COMPANY INFORMATION


Director
David Young 




Registered number
03514931



Registered office
5 Tanners Drive
Blakelands

Milton Keynes

Buckinghamshire

England

MK14 5BU




Independent auditor
Forvis Mazars LLP
Chartered Accountants & Statutory Auditor

The Pinnacle

160 Midsummer Boulevard

Milton Keynes

MK9 1FF





 
STARLAB (UK), LTD.
 

CONTENTS



Pages
Strategic Report
1 - 3
Director's Report
4 - 5
Independent Auditor's Report
6 - 9
Statement of Comprehensive Income
10
Statement of Financial Position
11 - 12
Statement of Changes in Equity
13
Notes to the Financial Statements
14 - 32


 
STARLAB (UK), LTD.
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

Introduction
 
The Director presents the Strategic Report for Starlab (UK), Ltd. for the year ended 31 December 2025.

Principal activities
 
The principal activities of the Company continued to be the distribution of high quality laboratory consumables and servicing and collaboration of these products.
Business review
The Director is satisfied with the trading performance during the year and is confident that this will continue in the coming year.
Sales increased due to improving economic conditions in the United Kingdom ("UK") in general. Product supply issues were resolved across 2024 and 2025 and this resulted in turnover increasing from £25,699k to £26,503k. A focus on customers has enabled the Company to maintain market share in a competitive environment.
Profit before tax decreased from £2,372k to £2,342k, a decrease of 1%.

Key performance indicators
 
Management use a range of performance measures to monitor and manage the business. The performance measures are split into financial and non-financial key performance indicators as set out below.
Financial key performance indicators

2025
2024
£000's 
      £000's
     % change

Turnover

26,503

25,699

3
 
Gross profit

9,120

9,322

(2)
 
Profit before tax

2,342

2,372

(1)
 
Net assets

7,066

7,117

(1)
 

Non-financial key performance indicators
 
2025
2024
       No
       No

Average number of employees

96

102



Future developments

The management team continues to be focused on maintaining improvements and making gains in all areas of the business. Specialising in liquid handling technology, the Company aims to provide the UK Laboratory market with the very highest quality goods and unrivalled levels of service.

Page 1

 
STARLAB (UK), LTD.
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025

Principal risks and uncertainties

Market and competitive risks
Starlab (UK), Ltd. operates significantly in the academia sector. Strong customer focus reduces the risk of losing customers and helps to protect market share. The Company operates in a competitive market but the Director feels that since the turnover is spread over multiple product lines and UK geographical regions there is minimal risk to the business.
Economic impact of global events
UK businesses are currently facing many uncertainties such as the consequences of environmental sustainability and geographical and political events. These uncertainties have contributed to an environment where there exists a range of issues and risks, including inflation, higher interest rates, labour shortages, disrupted supply chains and continued new ways of working.
The Director has carried out an assessment of the potential impact of all of these uncertainties which impact the business, including the impact of mitigation measures, and have concluded that these are non-adjusting events with the greatest impact on the business expected to be from the economic ripple effect on the global economy. The Director has taken account of these potential impacts in their going concern assessment.
Financial risks
The management of the business is subject to a number of financial risks. Financial risk management is discussed below.

Financial risk management

The main risks arising from the Company's financial instruments are liquidity and cash flow risk, currency risk and price risk. The Director reviews and agrees to the policies for managing each of these risks and they are summarised below.
These policies have remained unchanged from previous years:

Liquidity and cash flow risks
The business is currently in a strong financial position and is able to meet debts as they become due. 
The spread of different product lines reduces the potential adverse impact of a single product group on Company cash flow. The Director believes that the Company has sufficient funds available to withstand any difficulties which may arise in the next 12 months.

Currency risks
The Director is confident that as a result of the strong Statement of Financial Position and actions taken the business is positively positioned in the market. Whilst a significant proportion of the Company's suppliers are in overseas markets, a large proportion of currency risk is borne by the Company's immediate parent undertaking. 
Price risks
The Company strives to balance opposing price pressures from suppliers and customers. Increases in customer pricing are kept to the minimum to always give customers the best deal possible. All areas of cost are regularly reviewed to identify potential savings and efficiency gains.

Page 2

 
STARLAB (UK), LTD.
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025


This report was approved by the Board and signed on its behalf.




David Young
Director

Date: 26 June 2026

Page 3

 
STARLAB (UK), LTD.
 
 
 
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

The Director presents his report and the financial statements for the year ended 31 December 2025.

Director's responsibilities statement

The Director is responsible for preparing the Strategic Report, the Director's Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the Director to prepare financial statements for each financial year. Under that law the Director has elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 101 ‘Reduced Disclosure Framework’. Under company law the Director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the Director is required to:


select suitable accounting policies and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The Director is responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable him to ensure that the financial statements comply with the Companies Act 2006He is also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The profit for the year, after taxation, amounted to £1,749k (2024 - £1,776k).

Dividends were paid in the year of £1,800k (2024 - £2,000k).

Directors

The Directors who served during the year and up until the date of signing, unless otherwise stated, were:

David Young (appointed 5 February 2026)
Klaus Jean Ambos (resigned 5 February 2026)

Going concern

The financial statements have been prepared on the going concern basis which assumes that the Company will continue in operational existence for the foreseeable future, a period of not less than 12 months from the date of approval of these financial statements. The Director has reviewed cash flow forecasts and is confident that the Company will be able to pay its liabilities as they fall due. No material uncertainties have been identified or assessed. On this basis, the Director considers it appropriate to prepare the financial statements on the going concern basis.

Page 4

 
STARLAB (UK), LTD.
 
 
 
DIRECTOR'S REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025

Matters covered in the Strategic Report

As permitted by paragraph IA of Schedule 7 to the Large and Medium-sized Companies (Accounts and reports) Regulation 2009 certain matters which are required to be disclosed in the Director's Report have been omitted as they are included in the Strategic Report on pages 1-3. These matters relate to principal activities, business review, key performance indicators, principal risks and uncertainties and financial risk management.

Disclosure of information to auditor

The Director at the time when this Director's Report is approved has confirmed that:
 
so far as the Director is aware, there is no relevant audit information of which the Company's auditor is unaware, and

the Director has taken all the steps that ought to have been taken as a Director in order to be aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

Events subsequent to the reporting date

There have been no significant events affecting the Company since the year end.

Independent auditor

The auditor, Forvis Mazars LLPwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





David Young
Director

Date: 26 June 2026

Page 5

 
STARLAB (UK), LTD.
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF STARLAB (UK), LTD.
 


Opinion

We have audited the financial statements of Starlab (UK), Ltd. ("the Company") for the year ended 31 December 2025 which comprise the Statement of Comprehensive Income, the Statement of Financial Position, the Statement of Changes in Equity and notes to the financial statements, including a summary of material accounting policies. 
The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 101 “Reduced Disclosure Framework” (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

give a true and fair view of the state of the Company’s affairs as at 31 December 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the Director with respect to going concern are described in the relevant sections of this report.

Page 6

 
STARLAB (UK), LTD.
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF STARLAB (UK), LTD.
 

Other information

The other information comprises the information included in the Annual Report, other than the financial statements and our Auditor’s Report thereon. The Director is responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:
 
the information given in the Strategic Report and the Director's Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Director's Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Director's Report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of Director's remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.

Page 7

 
STARLAB (UK), LTD.
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF STARLAB (UK), LTD.
 

Responsibilities of Director

As explained more fully in the Director's responsibilities statement set out on page 4, the Director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Director is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Director intends either to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor’s Report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
 
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
 
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. 

Based on our understanding of the Company and its industry, we considered that non-compliance with the following laws and regulations might have a material effect on the financial statements: employment regulation, health and safety regulation, bribery act, data protection act, and anti-money laundering regulation.

To help us identify instances of non-compliance with these laws and regulations, and in identifying and assessing the risks of material misstatement in respect to non-compliance, our procedures included, but were not limited to:
Inquiring of management and, where appropriate, those charged with governance, as to whether the Company is in compliance with laws and regulations, and discussing their policies and procedures regarding compliance with laws and regulations;
Inspecting correspondence, if any, with relevant licensing or regulatory authorities;
Communicating identified laws and regulations to the engagement team and remaining alert to any indications of non-compliance throughout our audit; and
Considering the risk of acts by the Company which were contrary to applicable laws and regulations, including fraud.  

We also considered those laws and regulations that have a direct effect on the preparation of the financial statements, such as tax legislation, pension legislation, the Companies Act 2006. 
Page 8

 
STARLAB (UK), LTD.
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF STARLAB (UK), LTD.
 

Auditor's responsibilities for the audit of the financial statements (continued)
In addition, we evaluated the directors' and management's incentives and opportunities for fraudulent manipulation of the financial statements, including the risk of management override of controls, and determined that the principal risks related to posting manual journal entries to manipulate financial performance, management bias through judgements and assumptions in significant accounting estimates, revenue recognition (which we pinpointed to the occurrence assertion), and significant one-off or unusual transactions.

Our audit procedures in relation to fraud included but were not limited to:
Making enquiries of the Directors and management on whether they had knowledge of any actual, suspected or alleged fraud;
Gaining an understanding of the internal controls established to mitigate risks related to fraud;
Discussing amongst the engagement team the risks of fraud; and
Addressing the risks of fraud through management override of controls by performing journal entry testing. 

There are inherent limitations in the audit procedures described above and the primary responsibility for the prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at 
www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor’s Report.

Use of the audit report

This report is made solely to the Company's members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body for our audit work, for this report, or for the opinions we have formed.

 


 
Daniel Harvey (Senior Statutory Auditor)

  
for and on behalf of
Forvis Mazars LLP
Chartered Accountants and Statutory Auditor 
The Pinnacle
160 Midsummer Boulevard
Milton Keynes
MK9 1FF

2 July 2026
Page 9

 
STARLAB (UK), LTD.
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025

2025
2024
Note
£
£

  

Turnover
 4 
26,502,961
25,699,307

Cost of sales
  
(17,382,588)
(16,377,788)

Gross profit
  
9,120,373
9,321,519

Selling and distribution costs
  
(4,390,864)
(4,814,524)

Administrative expenses
  
(2,535,450)
(2,321,225)

Other operating income
 5 
162,916
208,993

Operating profit
 6 
2,356,975
2,394,763

Interest receivable and similar income
 10 
15,800
-

Interest payable and similar expenses
 14 
(30,885)
(22,466)

Profit before tax
  
2,341,890
2,372,297

Tax on profit
 11 
(592,428)
(596,240)

Profit for the financial year and comprehensive income
  
1,749,462
1,776,057

There was no other comprehensive income for 2025 (2024 - £Nil).
These results arise from continuing operations.

The notes on pages 14 to 32 form part of these financial statements.

Page 10

 
STARLAB (UK), LTD.
REGISTERED NUMBER: 03514931

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 13 
340,060
421,798

Right-of-use assets
 14 
724,800
844,837

  
1,064,860
1,266,635

Current assets
  

Stocks
 15 
2,884,414
2,935,419

Debtors
 16 
3,187,205
3,093,209

Cash and cash equivalents
 17 
3,368,922
2,340,748

  
9,440,541
8,369,376

Creditors: amounts falling due within one year
 18 
(2,737,168)
(1,654,026)

Net current assets
  
 
 
6,703,373
 
 
6,715,350

Total assets less current liabilities
  
7,768,233
7,981,985

  

Creditors: amounts falling due after more than one year
 19 
(391,714)
(544,539)

  
7,376,519
7,437,446

Provisions for liabilities
  

Deferred taxation
 20 
(60,068)
(70,457)

Provisions
 21 
(250,000)
(250,000)

  
 
 
(310,068)
 
 
(320,457)

Net assets
  
7,066,451
7,116,989


Capital and reserves
  

Called up share capital 
 22 
600,000
600,000

Retained earnings
 23 
6,466,451
6,516,989

Total equity
  
7,066,451
7,116,989


Page 11

 
STARLAB (UK), LTD.
REGISTERED NUMBER: 03514931
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2025

The financial statements were approved and authorised for issue by the Board and were signed on its behalf  by: 




David Young
Director

Date: 26 June 2026

The notes on pages 14 to 32 form part of these financial statements.

Page 12

 
STARLAB (UK), LTD.
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025


Called up share capital
Retained earnings
Total equity

£
£
£

At 1 January 2025
600,000
6,516,989
7,116,989


Comprehensive income for the year

Profit for the year
-
1,749,462
1,749,462
Total comprehensive income for the year
-
1,749,462
1,749,462

Dividends: Equity capital (note 12)
-
(1,800,000)
(1,800,000)


At 31 December 2025
600,000
6,466,451
7,066,451



STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Retained earnings
Total equity

£
£
£

At 1 January 2024
600,000
6,740,932
7,340,932


Comprehensive income for the year

Profit for the year
-
1,776,057
1,776,057
Total comprehensive income for the year
-
1,776,057
1,776,057

Dividends: Equity capital (note 12)
-
(2,000,000)
(2,000,000)


At 31 December 2024
600,000
6,516,989
7,116,989


The notes on pages 14 to 32 form part of these financial statements.

Page 13

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

Starlab (UK), Ltd. ("the Company") is a private company limited by shares, registered in England and Wales and incorporated in the United Kingdom. Company registered number 03514931. The address of its registered office and principal place of business is disclosed on the Company information page.
The principal activities of the Company continued to be the distribution of high quality laboratory consumables and servicing and collaboration of these products.
These financial statements have been presented in Pounds Sterling (£), this being the functional currency of the Company and currency of its primary economic environment.
Monetary amounts within these financial statements have been rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 101 'Reduced Disclosure Framework'  and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 101 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 101 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions under FRS 101:
the requirements of IFRS 7 Financial Instruments: Disclosures
the requirements of the second sentence of paragraph 110 and paragraphs 113(a), 114, 115, 118, 119(a) to (c), 120 to 127 and 129 of IFRS 15 Revenue from Contracts with Customers
the requirement in paragraph 38 of IAS 1 'Presentation of Financial Statements' to present comparative information in respect of:
 - paragraph 79(a)(iv) of IAS 1;
 - paragraph 73(e) of IAS 16 Property, Plant and Equipment;
 - paragraph 118(e) of IAS 38 Intangible Assets;
the requirements of paragraphs 10(d), 10(f), 16, 38A, 38B, 38C, 38D, 40A, 40B, 40C, 40D, 111 and 134-136 of IAS 1 Presentation of Financial Statements
the requirements of IAS 7 Statement of Cash Flows
the requirements of paragraphs 30 and 31 of IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors
the requirements of paragraph 17 and 18A of IAS 24 Related Party Disclosures
the requirements in IAS 24 Related Party Disclosures to disclose related party transactions entered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member
the requirements of paragraphs 130(f)(ii), 130(f)(iii), 134(d)-134(f) and 135(c)-135(e) of IAS 36 Impairment of Assets.
Page 14

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)


2.2
Financial Reporting Standard 101 - reduced disclosure exemptions (continued)

This information is included in the consolidated financial statements of Eppendorf SE as at 31 December 2025 and these financial statements may be obtained from Barkhausenweg 1, Hamburg, 22339, Germany.

 
2.3

Going concern

The financial statements have been prepared on the going concern basis which assumes that the Company will continue in operational existence for the foreseeable future, a period of not less than 12 months from the date of approval of these financial statements. The Director has reviewed cash flow forecasts and is confident that the Company will be able to pay its liabilities as they fall due. No material uncertainties have been identified or assessed. On this basis, the Director considers it appropriate to prepare the financial statements on the going concern basis.

  
2.4

Turnover recognition

Recognition
The Company earns turnover from its principal activities: 
•  The distribution of high quality laboratory consumables; and
•  Servicing and collaboration of these products.
Turnover is recognised at an amount that reflects the consideration to which the entity expects to be entitled in exchange for fulfilling its performance obligations to customers.
The principles of IFRS 15 are applied to revenue recognition criteria using the following 5 step model:
 
1.Identify the contracts with the customer
2.Identify the performance obligations in the contract
3.Determine the transaction price
4.Allocate the transaction price for the performance obligations in the contract
5.Recognise turnover when or as the entity satisfies its performance obligations

Turnover from the sale of goods is recognised when control of the products has transferred, being on signed acceptance by the customer, usually on delivery.
Turnover from services is recognised upon completion of the services.
Turnover is adjusted resulting from a refund or return at the point of receipt of the goods, all warranty obligations are met at point of return from a customer.

The transaction price is the fair value of the consideration received for the product less discounts and value added taxes.
Payment of the transaction price is due immediately when control has passed to the customer subject to agreed credit terms.
A receivable is recognised when the goods are delivered or the service is completed, as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

Page 15

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Interest payable and similar expenses

Interest payable and similar expenses are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.7

Intangible assets

Intangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.
Intangible assets with finite lives are amortised over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired.

The intangible assets have finite, useful lives, and will be amortised on a straight line basis over the following useful life:

Software
-
25%
per annum straight line

The amortisation period and the amortisation method are reviewed at least at each financial year end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortisation period or method, as appropriate, and are treated as changes in accounting estimates.
Gains or losses arising from derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the carrying amount of the asset and are recognised in the income statement when the asset is derecognised.
Costs associated with maintaining computer software are recognised as an expense as incurred.

Page 16

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.8

Tangible assets

Tangible assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Depreciation is provided on all tangible assets at rates calculated to write off the cost or valuation, less estimated residual value based on prices prevailing at the date of acquisition or revaluation, of each asset evenly over its expected useful life, as follows:

          Improvement to leasehold property      straight line over the lease period

Equipment
-
25% - 33% per annum straight line

The carrying values of tangible assets are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable.
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

  
2.9

Right-of-use-assets

The Company has lease contracts for various the building and vehicles used in operations. The lease on the building has a term of 10 years and vehicles of 3 years. The obligations under its leases are secured by the lessor's title to the leased assets. The Company is restricted from assigning and subleasing the leased assets.

  
2.10

Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost is calculated using a first-in-first out method and consists of material costs together with an applicable proportion of freight and duty.

  
2.11

Current taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date.

Page 17

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

  
2.12

Deferred taxation

Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the Statement of Financial Position date where transactions or events have occurred at that date that will result in an obligation to pay more, or right to pay less or to receive more, tax, with the following exception:
Deferred tax assets are recognised only to the extent that the Director considers that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.
Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the Statement of Financial Position date.

  
2.13

Lease liabilities

The Company recognises the lease liabilities at the present value of lease payments to be made over the lease term. Lease payments include fixed payments less any incentives receivable.
In calculating the present value of the lease payments, the Company uses an incremental borrowing rate at the lease commencement date.
After commencement, the lease liabilities are increased to reflect the added interest and reduced lease payments which are made.
In the case where a modification of the lease exists, the carrying amount of the lease shall be remeasured to reflect this.

  
2.14

Pensions

The Company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Company to the fund in respect of the year.

  
2.15

Provisions for liabilities

A provision is recognised when the Company has a legal or constructive obligation as a result of a past event; it is probable that an outflow of economic benefits will be required to settle the obligation; and a reliable estimate can be made of the amount of the obligation. If the effect is material, expected future cash flows are discounted using a current pre-tax rate that reflects, where appropriate, the risks specific to the liability.
Where the Company expects some or all of a provision to be reimbursed, the reimbursement is recognised as a separate asset but only when recovery is virtually certain. The expense relating to any provision is presented in the income statement net of any reimbursement. Where discounting is used, the increase in the provision due to unwinding the discount is recognised as a finance cost.

Page 18

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.16

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is Pounds Sterling (£).

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in the Statement of Comprehensive Income within 'other operating income'.

 
2.17

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.18

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.19

Creditors

Creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Creditors are recognised initially at fair value and subsequently measured at amortised cost using the effective interest method.

Page 19

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

  
2.20

Financial instruments

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.
Financial asset - recognition and measurement
Financial assets are recognised when the entity becomes a party to the contract and, as a consequence, has a legal right to receive cash.
All recognised financial assets are subsequently measured in their entirety at either amortised cost or fair value, depending on the classification of the financial assets.
The Company classifies its financial assets in the following categories: at fair value through Statement of Comprehensive Income; and loans and receivables. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

a)Financial assets at fair value through profit or loss or at fair value through other comprehensive income
There are no instruments which have been classified under this category.
 
b)Financial assets at amortised cost

The Company classifies its financial assets as at amortised cost only if both of the following criteria are met

the asset is held within a business mode whose objective is to collect the contractual cashflows
the contractual terms give rise to cash flows that are solely payments of principal and interest.

This category is the most relevant to the Company. After initial measurement, such financial assets are subsequently measured at amortised cost. The losses arising from impairment are recognised in the Statement of Comprehensive Income.

Impairment of financial assets
In accordance with IFRS 9 the Company applies the expected credit loss ("ECL") model for measurement and recognition of impairment loss on the following financial assets and credit risk exposure:

a)Financial assets that are debt instruments, and are measured at amortised cost: e.g; loans, debt securities. deposits, trade receivables and bank balance;
b)Trade receivables or any contractual right to receive cash or another financial asset that result from transactions that are within the scope of IFRS 15.
 
Page 20

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

Financial instruments (continued)
For trade and other receivables, the Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables. To measure the expected credit losses trade receivables have been grouped based on shared credit risk characteristics and the days past due.

Financial liabilities - recognition and measurement
Financial liabilities are classified, at initial recognition.
All financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.
The Company's financial liabilities comprise of trade creditors and amount owed to group undertakings.
Subsequent measurement
The measurement of financial liabilities depends on their classification, as described below:
 
a)Financial liabilities at fair value through the Statement of Comprehensive Income
b)Loan's and borrowings

The Company does not have any financial liabilities which are subsequently re-measured at fair value through Statement of Comprehensive Income.
De-recognition
A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the de-recognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognised in the statement of Comprehensive Income.
Offsetting financial instruments
Financial assets and liabilities are offset and the net amount is reported in the Statement of Financial Position where there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously.

 
2.21

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 21

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In applying the Company's accounting policies, the Director is required to make judgements, estimates and assumptions in determining the carrying amounts of assets and liabilities. The Director's estimates and assumptions are based on the best and most reliable evidence available at the time when the decisions are made, and are based on historical experience and other factors that are considered to be applicable. Due to the inherent subjectivity involved in making such estimates and assumptions, the actual results and outcomes may differ.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of revision and future periods, if the revision affects both current and future periods.
Critical judgements in applying the Company's accounting policies
In the opinion of the Director, there are no significant judgements in the preparation of the financial statements.
Key sources of estimation uncertainty
The key sources of estimation uncertainty, that have had a risk of causing an adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below:
Impairment review of stock
Slow and obsolete stock provisions are reviewed on a line by line basis and appropriate provisions are recorded as necessary. The Company provides for stock deemed to be obsolete. The provision is based on the ratio of historical information of sales and usages compared to quantities of stock held.


4.


Turnover

Analysis of turnover by country of destination:

2025
2024
£
£

United Kingdom
26,502,961
25,699,307


The turnover is mainly attributable to the distribution of high quality laboratory consumables. 17%  (2024 - 16%) of turnover was generated from servicing and calibration of these products. 


5.


Other operating income

2025
2024
£
£

Service fees recharged to group
162,916
208,993

162,916
208,993


Page 22

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

6.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Depreciation of owned tangible assets
189,463
239,661

Depreciation of right of use assets
363,469
265,203

Exchange differences
-
206


7.


Auditor's remuneration

During the year, the Company obtained the following services from the Company's auditor:


2025
2024
£
£

Fees payable to the Company's auditor for the audit of the Company's financial statements
41,500
32,000

Fees payable to the Company's auditor in respect of:

All non-audit services
20,517
16,926


8.


Employees

Staff costs, including Director's remuneration, were as follows:


2025
2024
£
£

Wages and salaries
3,773,676
3,593,775

Social security costs
476,639
397,278

Cost of defined contribution scheme
213,580
330,389

4,463,895
4,321,442


The average monthly number of employees, including the Director, during the year was as follows:


        2025
        2024
            No.
            No.







Total employees
96
102

Page 23

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

9.


Director's remuneration

2025
2024
£
£

Director's emoluments
-
63,016

Company contributions to defined contribution pension schemes
-
8,495

-
71,511


During the year retirement benefits were accruing to no Director (2024 - 1) in respect of defined contribution pension schemes.

The Company considers the Director to be the only key management personnel. Their remuneration is shown above.
In 2025, the Director was remunerated by a Group company.


10.


Interest receivable

2025
2024
£
£


Other interest receivable
15,800
-

15,800
-

These relate to interest income on tax receivable from HMRC.


11.


Taxation


2025
2024
£
£

Corporation tax


Current tax on profits for the year
602,817
588,050

Adjustments in respect of previous periods
-
(3,989)


Total current tax
602,817
584,061

Deferred tax


Current year
(10,389)
12,179


Tax on profit
592,428
596,240
Page 24

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
 
11.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 - higher than) the standard rate of corporation tax in the UK of 25% (2024: 25%). The differences are explained below:

2025
2024
£
£


Profit on ordinary activities before tax
2,341,890
2,372,297


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 -  25%)
585,473
593,074

Effects of:


Expenses not deductible for tax purposes
6,955
7,155

Adjustments in respect of prior periods
-
(3,989)

Total tax charge for the year
592,428
596,240


Factors that may affect future tax charges

There were no factors that may affect future tax charges.


12.


Dividends

2025
2024
£
£


Dividends paid of £3.00 per share (2024 - £3.33 per share)
1,800,000
2,000,000

Page 25

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

13.


Tangible fixed assets





Improvement
to leasehold premises
Office equipment
Total

£
£
£



Cost or valuation


At 1 January 2025
889,799
1,206,922
2,096,721


Additions
-
107,725
107,725


Disposals
-
(137,792)
(137,792)



At 31 December 2025

889,799
1,176,855
2,066,654



Depreciation


At 1 January 2025
889,799
785,124
1,674,923


Charge for the year 
-
189,463
189,463


Disposals
-
(137,792)
(137,792)



At 31 December 2025

889,799
836,795
1,726,594



Net book value



At 31 December 2025
-
340,060
340,060



At 31 December 2024
-
421,798
421,798

Page 26

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

14.

Right-of-use assets

Right-of-use assets recognised in the Statement of Financial Position are as follows:


       Buildings
Motor vehicles
         Total

£
£
£

Cost

At 1 January 2025
1,295,812
820,339
2,116,151

Additions
-
304,208
304,208

Disposals
-
(107,512)
(107,512)


At 31 December 2025
1,295,812
1,017,035
2,312,847


Depreciation

At 1 January 2025
1,097,840
173,474
1,271,314

Charge for the year
107,984
255,485
363,469

Disposals 
-
(46,736)
(46,736)


At 31 December 2025
1,205,824
382,223
1,588,047


Net book value

At 31 December 2025
89,988
634,812
724,800


At 31 December 2024
197,972
646,865
844,837


Nature of leases 
The Company has leases for the main warehouse, office building and related facilities, along with motor vehicles. With the exception of short-term leases and leases of low-value underlying assets, each lease is reflected in the Statement of Financial Position as a right-of­ use asset and a lease liability. Variable lease payments which do not depend on an index or a rate (such as lease payments based on a percentage of sales) are excluded from the initial measurement of the lease liability and asset. The Company classifies its right-of-use assets in a consistent manner to its Tangible Fixed Assets (see note 13).
Each lease generally imposes a restriction that, unless there is a contractual right for the Company to sublet the asset to another party, the right-of-use asset can only be used by the Company. Leases are either non-cancellable or may only be cancelled by incurring a termination fee.
Certain leases contain an option to purchase the underlying leased asset at the end of the lease term, or to extend the lease for a further term. The Company is prohibited from selling or pledging the underlying leased assets as security. For leases over office buildings and warehouse premises the Company must keep those properties in a good state of repair and return the properties in their original condition at the end of the lease. Further, the Company must insure right-of-use assets and incur maintenance fees on such items in accordance with the lease contracts.
 


Page 27

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

14.Right-of-use assets (continued)



Lease liabilities included in the Statement of Financial Position:


2025
2024

£
£


Current (note 18)
357,642
325,086

Non-current (note 19)
391,714
544,539


749,356
869,625

Additions to the right-of-use assets during the 2025 financial year were £304,208 (2024: £670,062).




The Statement of Comprehensive Income shows the following amounts relating to leases:


2025
2024

£
£

Depreciation charge on right-of-use assets

Buildings
107,984
107,984

Motor vehicles
255,485
157,219


363,469
265,203

Interest expense on lease liabilities
30,885
22,466



Company
2025
2024

£
£


Cash payment - principal portion
393,309
286,462

Cash payment - interest portion
30,885
22,466


424,194
308,928

Page 28

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

15.


Stocks

2025
2024
£
£

Finished goods and goods for resale
2,884,414
2,935,419

2,884,414
2,935,419


Stocks are stated after a stock provision during the year of £604,664 (2024 - £473,867).



16.


Debtors

2025
2024
£
£

Trade debtors
2,521,403
2,440,275

Amounts owed by fellow subsidiary undertakings
42,240
69,582

Other debtors
465,910
409,755

Prepayments and accrued income
157,652
173,597

3,187,205
3,093,209


Trade debtors are stated after provisions for impairment of £38,780 (2024 - £36,142).
Management believe there is no further expected credit loss provision required in excess of the normal provisions for impairments noted at year end. Management also deem the whole provision to be immaterial.
The amounts owed by group undertakings comprise an amount related to standard trading activities which are unsecured, interest free and have no fixed repayment dates.


17.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
3,368,922
2,340,748


Page 29

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

18.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
222,690
328,911

Amounts owed to immediate parent company
1,063,076
322,581

Other taxation and social security
408,660
140,928

Lease liabilities (note 14)
357,642
325,086

Accruals and deferred income
685,100
536,520

2,737,168
1,654,026


The amounts owed to immediate parent company comprise an amount related to standard trading activities which are unsecured, interest free and have no fixed repayment dates.
During the year the Company continued to hold banking facilities with HSBC. Fixed and floating charges over the assets of the Company (both present and future), have been given as security against these facilities. These facilities remain unused at the year end.


19.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Lease liability (note 14)
391,714
544,539


Page 30

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

20.


Deferred taxation liability




2025
2024


£

£






At beginning of year
(70,457)
(58,278)


Charged to profit or loss
10,389
(12,179)



At end of year
(60,068)
(70,457)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Fixed asset timing differences
(60,068)
(70,457)

(60,068)
(70,457)


21.


Provisions




Dilapidations

£





At 1 January 2025
250,000



At 31 December 2025
250,000

The dilapidation provision represents the expected future obligations for the restoration of the leasehold property back to its original state on termination of the lease.


22.


Called up share capital

2025
2024
£
£
Authorised, allotted, called up and fully paid



600,000 (2024 - 600,000) Ordinary  shares of £1.00 each
600,000
600,000

Each Ordinary share carries a voting right but no right to fixed income.


Page 31

 
STARLAB (UK), LTD.
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

23.


Reserves

Retained earnings

Retained earnings represents the cumulative profits and losses of the Company, less the payment of any dividends.


24.


Pension commitments

The Company operates a defined contribution scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund together with contributions to employees' personal pension schemes and amounted to £213,580 (2024 - £330,389).
Amount outstanding at year end is £Nil (2024 - £Nil).


25.


Related party transactions

The Company has taken advantage of the exemption under Paragraph 8(k) of FRS101 not to disclose transactions with group companies as it is a wholly owned subsidiary of Eppendorf SE, whose financial statements are publicly available.


26.


Events subsequent to the reporting date

There are no events subsequent to the reporting date that require disclosure in these financial statements.


27.


Controlling party

At 31 December 2025, the Company's immediate parent undertaking party was STARLAB International GmbH, a Company registered in Germany. The group financial statements of Eppendorf SE, being the parent undertaking of the largest and smallest group to consolidate the results, are published by the elektronischer Bundesanzeiger (www.ebundesanzeiger.de). The Directors regard ACEG Beteiligungsgesellschaft mbH to be the ultimate controlling party.

Page 32